Log in
NYSEARCA:IBDV

iShares iBonds Dec 2030 Term Corporate ETF Stock Forecast, Price & News

$25.69
-0.06 (-0.23 %)
(As of 10/22/2020 12:00 AM ET)
Add
Today's Range
$25.66
Now: $25.69▼
$25.74
50-Day Range
$25.62
MA: $25.81▼
$26.01
52-Week Range
$25.17
Now: $25.69▼
$26.90
Volume8,367 shs
Average Volume15,002 shs
Market Capitalization$34.68 million
P/E RatioN/A
Dividend Yield0.47%
BetaN/A

Geographic Exposure of IBDV

Currency Exposure of IBDV

Sector Exposure of IBDV

Industry Exposure of IBDV

Basic Details

Issuer iShares
Fund NameiShares iBonds Dec 2030 Term Corporate ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IBDV
Inception Date6/23/2020
Fund ManagerJames Mauro, Scott Radell
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBloomberg Barclays December 2030 Maturity Corporate Index
CategoryCorporate
FocusInvestment Grade
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$34.68 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.10%
Other Expenses0.00%
Total Expenses0.10%
Fee Waiver0.00%
Net Expenses0.10%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker
$25.69
-0.06 (-0.23 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IBDV News and Ratings via Email

Sign-up to receive the latest news and ratings for IBDV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iShares iBonds Dec 2030 Term Corporate ETF (NYSEARCA:IBDV) Frequently Asked Questions

What other stocks do shareholders of iShares iBonds Dec 2030 Term Corporate ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares iBonds Dec 2030 Term Corporate ETF investors own include ABIOMED (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), Arca Biopharma (ABIO), AbbVie (ABBV) and Audioeye (AEYE).

What is iShares iBonds Dec 2030 Term Corporate ETF's stock symbol?

iShares iBonds Dec 2030 Term Corporate ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IBDV."

Who are iShares iBonds Dec 2030 Term Corporate ETF's major shareholders?

iShares iBonds Dec 2030 Term Corporate ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Confluence Investment Management LLC (50.50%).

Which institutional investors are buying iShares iBonds Dec 2030 Term Corporate ETF stock?

IBDV stock was purchased by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC.

How do I buy shares of iShares iBonds Dec 2030 Term Corporate ETF?

Shares of IBDV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares iBonds Dec 2030 Term Corporate ETF's stock price today?

One share of IBDV stock can currently be purchased for approximately $25.69.

How big of a company is iShares iBonds Dec 2030 Term Corporate ETF?

iShares iBonds Dec 2030 Term Corporate ETF has a market capitalization of $34.68 million.

This page was last updated on 10/23/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.